Medical Oncology

3

Review clinical trials related to Medical Oncology. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies

The main idea of this study is that a low protein diet may alter the environment surrounding the tumor, enhancing the body's immune response leading to greater anticancer effects of treatment. This study intends to use a low-protein diet as a tool to enhance the immune response generated by immune check point inhibitor treatments.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: State University of New York at BuffaloUpdated: Apr 3, 2026Locations: 1
Eligibility criteria

Histologically documented solid tumor malignancies which is amenable for immunot... [+11]

• Eastern Cooperative Oncology Group (ECOG) performance status 2 or higher [+6]

Status: Recruiting

A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy

Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard treatment of cancer.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: State University of New York at BuffaloUpdated: Feb 20, 2026Locations: 2
Eligibility criteria

• Histologically documented, cancer patients who are eligible to receive cytotox... [+10]

• Eastern Cooperative Oncology Group (ECOG) performance status 2 or higher [+5]

Status: Recruiting

Improvement of Quality of Life by Cannabinoids in Oncologic Patients

The goal is to explore whether the application of cannabis extract Avextra 10/10 solution is suitable to contribute to an improvement in the symptom burden and well-being of oncological palliative care patients. The primary objective of the study is to demonstrate the improvement in global symptom burden in the intervention arm compared to the placebo control group over a period of 12±2 days, as measured by a percentage change in the value of the Edmonton Symptom Assessment System total symptom distress score (ESAS TSDS) at baseline and after 12±2 days.

Participants needed: 170
Trial details
Phase: Phase 2Age: 25+Biological sex: AllType: InterventionalSponsor: University Hospital Schleswig-HolsteinUpdated: Oct 26, 2024Locations: 4
Eligibility criteria

≥25 years old and legally competent [+8]

nausea > or equals grade 3 (CTCAE) or vomiting > or equals grade 2 (CTCAE) in th... [+7]